Paju, South Korea

Yoon-Keun Kim

This inventor holds 38 USPTO granted patents and 46 published patent applications, plus 2 CIPO patents and 19 EPO patents, primarily in Bacterial Nanovesicles. Top assignees: MD Healthcare Inc., MD Aptus Inc., Pohang University of Science and Technology Foundation. Active years: 2014-2025.

USPTO Granted Patents = 38 

% Patents Active = 94.7

 

 

Average Co-Inventor Count = 1.4

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Pohang, KR (2014)
  • Seoul, KR (2016)
  • Paju, KR (2020)
  • Namyangju-si, KR (2019 - 2023)
  • Paji-Si, KR (2022 - 2023)
  • Paju-si, KR (2019 - 2024)
  • Gyeonggi-do, KR (2021 - 2024)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Bacterial Metagenomics
Nanovesicles
Ovarian Cancer Diagnosis
Inflammatory Bowel Disease
Neurodevelopmental Disorders
Extracellular Vesicles
Viral Infection Treatment
Cancer Therapy
DNA Aptamers
Pathogen Identification
Psychiatric Diseases
Immune Disorders
38 patents (USPTO):Explore Patents

**Title: Innovations of Yoon-Keun Kim: A Pioneer in Medical Diagnostics**

Introduction

Yoon-Keun Kim is a prominent inventor based in Paju-si, South Korea, holding an impressive portfolio of 36 patents. His work primarily focuses on innovative solutions that leverage bacterial-derived vesicles for medical diagnostics and treatments, offering new avenues for combating complex diseases.

Latest Patents

Kim's latest patents include groundbreaking inventions such as "Nanovesicles derived from bacteria of the genus and use thereof." This invention describes vesicles derived from specific bacteria, which were found to be significantly reduced in patients suffering from various diseases like diabetes, myocardial infarction, atrial fibrillation, stroke, renal failure, Parkinson's disease, and depression. These vesicles have shown promise in inhibiting the secretion of inflammation mediators caused by pathogenic vesicles, thereby providing potential methods for diagnosing and treating these conditions.

Another notable invention is the "Inflammatory bowel disease diagnostic method by means of bacterial metagenomic analysis." This method aims to prognosticate the occurrence of inflammatory bowel diseases like ulcerative colitis and Crohn's disease through metagenomic analysis of bacterial vesicles in human body-derived substances. The ability to analyze the metagenomic sequences to identify causative factors and risks enhances early diagnosis and improves therapeutic outcomes for patients.

Career Highlights

Throughout his career, Yoon-Keun Kim has made significant contributions to the field of biomedical innovation. He has worked with organizations such as Md Healthcare Inc. and Md Aptus Inc., where he focused on the intersection of microbiology and health diagnostics. His innovative approach to utilizing bacterial vesicles has transformed conventional methods of diagnosing and treating diseases.

Collaborations

Kim has collaborated with esteemed colleagues such as Changill Ban and Chulhun Chang. These partnerships have facilitated the advancement of his research and inventions, contributing to a collective effort in enhancing patient care and medical diagnostics.

Conclusion

Yoon-Keun Kim stands out as an influential inventor whose work significantly impacts the medical field. His pioneering patents not only advance our understanding of complex diseases but also pave the way for innovative diagnostic and therapeutic methods. With a commitment to improving healthcare outcomes, Kim's contributions are set to make a lasting difference in the lives of many patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…